-
Ubiquitome, the only company outside the US, has received NIH RADx funds to develop its open RT-PCR the Liberty16 to test for COVID-19 in US hospitals and mobile labs
Oct 5, 2020
-
Oct 7, 2020
-
Scanogen, a pioneer molecular diagnostic company delivering revolutionary diagnostic solutions for sepsis and other infectious diseases, announced the findings from a new study published in Nature Communications that demonstrate the ability of a new technology to detect pathogens in whole blood with superior performance than amplification-based molecular technologies. The novel approach is at the basis of the system that the Company is developing to dramatically reduce the time it takes to identify sepsis associated pathogens from days to one hour.
Sep 28, 2020
-
Swedish Biomimetics 3000 Ltd, a life science technology company which has developed a world leading green technology platform used in the continuous manufacturing of pharmaceuticals, has established a new head office and scientific research facilities in Copenhagen. The company, which is called Swedish Biomimetics 3000 ApS, believes that it will benefit from the sector specific expertise in Denmark in expanding its capabilities. Going forward, the company will have key operations in both the UK and Denmark.
Sep 27, 2020
-
Sep 27, 2020
-
Sep 27, 2020
-
Oct 1, 2020
-
Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investor. The capital raised will enable Panthera to further build out its network of clinical trial sites across the UK and overseas and increase its team of clinical trial experts in serving both pharma and patients.
Oct 1, 2020
-
VERICHEM LABORATORIES has announced the availability of a ready-to-use, liquid stable Electrolyte Standard Kit intended for the calibration and calibration verification of a number of diagnostic assays measured on a wide variety of clinical testing systems.
Oct 4, 2020
-
Oct 4, 2020
-
Oct 9, 2020
-
Oct 9, 2020
-
New in vitro Bioactivation Liver Response Assay used HEPATOPAC model to demonstrate utility of in vitro transcriptomic signature-based strategy in preclinical DILI risk assessment
Oct 11, 2020
-
WCG has unified its five IRBs – Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB, and Aspire IRB – in a single brand, WCG IRB. It has also launched a new technology – WCG IRB Connexus – to support clients’ ethical review submissions and management. Further information is available on it new website at www.wcgirb.com.
Oct 11, 2020
-
For busy hospital clinicians making key medication decisions, minutes matter. They need up-to-the-minute reliable, authoritative drug information integrated into the EHR for better clinical decision-making at the point of care and to support alerts, interoperability and smarter data analytics. With drug information changing daily, that information also needs to be updated as soon as evidence-based knowledge and FDA guidance change--and it needs to be available immediately via the cloud rather than requiring frequent downloads.
For all of those reasons, CliniComp Intl. has inked a deal with First Databank (FDB), the industry’s most trusted drug database, to drive streamlined inpatient pharmacy workflows for hospitals using the CliniComp’s EHR.
Oct 15, 2020
-
Applications for this model include assessing drug candidates’ hepatotoxicity, and studying inflammation-related diseases
Oct 18, 2020
-
Oct 19, 2020
-
Oct 20, 2020
-
SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology.
Oct 20, 2020
-
Sep 2, 2020